4/12
08:00 am
imrx
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
Low
Report
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
4/12
06:31 am
imrx
Rating for IMRX
Low
Report
Rating for IMRX
4/12
06:31 am
imrx
Rating for IMRX
Low
Report
Rating for IMRX
4/2
07:49 am
imrx
Rating for IMRX
High
Report
Rating for IMRX
4/2
07:49 am
imrx
Rating for IMRX
High
Report
Rating for IMRX
3/18
03:05 pm
imrx
Immuneering Co. (NASDAQ: IMRX) had its "neutral" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Immuneering Co. (NASDAQ: IMRX) had its "neutral" rating re-affirmed by analysts at Guggenheim.
3/18
03:05 pm
imrx
Immuneering Co. (NASDAQ: IMRX) had its "neutral" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Immuneering Co. (NASDAQ: IMRX) had its "neutral" rating re-affirmed by analysts at Guggenheim.
3/15
08:13 am
imrx
Rating for IMRX
High
Report
Rating for IMRX
3/15
08:13 am
imrx
Rating for IMRX
High
Report
Rating for IMRX
3/15
07:18 am
imrx
Rating for IMRX
High
Report
Rating for IMRX
3/15
06:52 am
imrx
Rating for IMRX
High
Report
Rating for IMRX
3/15
06:52 am
imrx
Rating for IMRX
High
Report
Rating for IMRX
3/14
04:08 pm
imrx
Rating for IMRX
High
Report
Rating for IMRX
3/14
04:08 pm
imrx
Rating for IMRX
High
Report
Rating for IMRX
3/11
10:37 am
imrx
Rating for IMRX
Medium
Report
Rating for IMRX
3/11
10:37 am
imrx
Rating for IMRX
Medium
Report
Rating for IMRX
3/5
08:14 am
imrx
Immuneering Co. (NASDAQ: IMRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $25.00 price target on the stock.
Low
Report
Immuneering Co. (NASDAQ: IMRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $25.00 price target on the stock.
3/5
07:55 am
imrx
Rating for IMRX
Low
Report
Rating for IMRX
3/5
07:55 am
imrx
Rating for IMRX
Low
Report
Rating for IMRX
3/4
08:06 am
imrx
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $20.00 price target on the stock.
Medium
Report
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $20.00 price target on the stock.
3/4
05:35 am
imrx
Rating for IMRX
Medium
Report
Rating for IMRX
3/4
05:35 am
imrx
Rating for IMRX
Medium
Report
Rating for IMRX
2/1
08:03 am
imrx
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $20.00 price target on the stock.
Low
Report
Immuneering Co. (NASDAQ: IMRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $20.00 price target on the stock.
2/1
07:32 am
imrx
Rating for IMRX
Low
Report
Rating for IMRX
2/1
07:32 am
imrx
Rating for IMRX
Low
Report
Rating for IMRX